South Korean pharmaceutical firm HLB Co. said Thursday its shareholders have given the green light to the company's move to transition its listing from the secondary KOSDAQ market to the primary KOSPI bourse. 

Please refer to the following website for further details : HLB's shareholders approve plan to move to main bourse from KOSDAQ | Yonhap News Agency (yna.co.kr)